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Abstract – A new in vitro model based on the electrical resistance properties of the skin 
barrier has been established in this laboratory.  The model utilises a tape stripping 
procedure in dermatomed pig skin that removes a specific proportion of the stratum 
corneum, mimicking impaired barrier function observed in humans with damaged skin.  
The skin penetration and distribution of chemicals with differing physicochemical 
properties, namely; Benzoic Acid, 3-Aminophenol, Caffeine and Sucrose has been 
assessed in this model.  Although, skin penetration over 24 h differed for each chemical, 
compromising the skin did not alter the shape of the time course profile, although 
absorption into receptor fluid was higher for each chemical.  Systemic exposure (receptor 
fluid, epidermis and dermis), was marginally higher in compromised skin following 
exposure to the fast penetrant, Benzoic acid, and the slow penetrant Sucrose.  The 
systemically available dose of 3-Aminophenol increased to a greater extent and the 
absorption of Caffeine was more than double in compromised skin, suggesting that 
Molecular Weight and Log Pow, are not the only determinants for assessing systemic 
exposure under these conditions.  Although further investigations are required, this in vitro 
model may be useful for prediction of dermal route exposure under conditions where skin 
barrier is impaired.   
 
Keywords:  Dermatomed pig skin; Electrical Resistance (ER); Barrier function; 
Compromised skin, Tape stripping; In vitro percutaneous absorption 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
3 
 
1. INTRODUCTION 
The assessment of the dermal absorption potential of ingredients in consumer, 
personal care, pharmaceutical and industrial chemical products that come into contact with 
the skin is a key part of human risk assessment.  This ensures that under normal or 
expected conditions, that there is a sufficient margin of safety for manufacturers, handlers 
and end users of products containing a particular chemical.  Dermal absorption is now 
almost exclusively determined using in vitro techniques and regulatory studies used for 
human risk assessment follow the in vitro OECD 428 test guideline using human or animal 
skin that has normal intact barrier properties.  This approach is used extensively by the 
personal care/cosmetic, biocide and agrochemical industries, together with specific 
guidance for the type of product used, in order to predict human exposure via the dermal 
route (EFSA, 2012; SCCS, 2010).  These in vitro protocols form part of the registration 
process that ensure the safety of new and existing products that come into contact with the 
skin either intentionally or during their occupational use. 
The OECD 428 test guideline has been used now for more than a decade as a stand-
alone in vitro model for dermal absorption assessment.  Current regulations for consumer 
products and chemicals use industry-specific protocols for dermal penetration.  Each of 
these guidance documents assume that the product will only come in contact with healthy, 
intact human skin (EFSA, 2012; SCCS, 2010).  However, there are product applications 
and consumer needs that involve potentially compromised skin and also industrial 
products may be used by individuals with compromised skin.  This research is aimed to 
bridge that gap by generating quantitative evidence of the extent of the difference between 
normal and compromised skin.  There are a number of previously published studies in this 
area that have used models of mechanically or chemically-damaged skin to determine 
quantitative changes in dermal exposure under such conditions (Dey, et al., 2014; Kezic 
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and Nielson, 2009;).  Although the damage to the skin barrier is quite different in 
conditions such as psoriasis or eczema compared with topical damage to the stratum 
corneum, similar in vitro approaches to that described in this investigation have also been 
utilised for chemicals used to treat skin diseases (Chiang et al., 2011; Goon et al., 2004; 
Jakasa et al., 2006).  However, these previous investigations were designed for specific 
scenarios and for specific chemical classes.  Furthermore, previous investigations using 
compromised skin have focused on the absorption of chemicals into the receptor fluid only, 
without considering the other regions of the skin beyond the stratum corneum that 
contribute to the “systemically available“ dose in regulatory studies.  Therefore, in this 
investigation we have also included the mass balance distribution of various reference 
chemicals in both normal and compromised skin, bringing it in line with modern day 
guidance used to estimate dermal absorption. 
A previous investigation in our laboratory published in this journal evaluated the 
potential of a new in vitro compromised skin model using a tape stripping technique in pig 
skin (Davies et al., 2015).  The objective of this previous research was to provide an in 
vitro experimental approach that could be used to investigate the dermal absorption of 
consumer products when the skin barrier was impaired (Davies et al., 2015), but distinct 
from fully abraded skin for which there is no stratum corneum barrier.  Assessment of 
dermal absorption through an impaired skin barrier is particularly important for certain 
products such as chaffed, cracked skin protectants, sunscreens and diaper rash creams, 
since they are often applied to the skin after the stratum corneum has already been 
damaged either by UV exposure or irritated by biological fluids in diaper dermatitis 
(Stamatas et al., 2011).  There is little knowledge as to the impact of such damage on 
dermal uptake for such products. The same could be argued for industrial chemicals and 
pesticides where they may be handled or sprayed by workers with damaged skin or by 
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individuals with skin conditions such as dermatitis, eczema or psoriasis.  We therefore set 
out to further develop a practical in vitro model of skin damage by tape stripping that was 
published recently in this journal (Davies et al., 2015).  In the previous investigation we 
had determined that a tape stripping regime that involved 10 sequential strips changed the 
barrier properties of the skin to a level that was equivalent to skin barrier damage in man, 
as assessed by the non-invasive integrity assessment, transepidermal water loss.  
In this follow up investigation we have evaluated how robust our model is and how 
useful it could be in a risk assessment context for the safety of chemicals that are used on 
damaged skin either intentionally or accidently.  The in vitro skin model has been 
evaluated using a number of reference chemicals that represented a range of molecular 
weights and polarities.  The chemicals selected for this exercise were Benzoic Acid, 3-
Aminophenol, Caffeine and Sucrose.  We have compared the dermal absorption 
properties of several of these reference chemicals in human skin in previous studies and 
across different laboratories (Heylings et al., 2007).  The purpose of this study was, 
therefore, to investigate the skin penetration and skin distribution of these chemicals in 
normal and compromised pig skin, based on the guidance for assessing systemic 
exposure via the dermal route, as used by the Scientific Committee on Consumer Safety 
for cosmetic ingredients (SCCS, 2010) and European Food Safety Authority for pesticide-
containing products (EFSA, 2012).  Both these industry groups base their guidance on the 
principles described in OECD test guideline 428 for in vitro dermal absorption (OECD, 
2004a). 
 
2. METHODS 
2.1 Preparation of dermatomed skin membranes 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
6 
 
Pig skin preparations used for this investigation were from animals of the British 
White strain of pig (aged 6-8 weeks) that had been bred for food and were sourced from a 
local abattoir.  Pig skin is a predictive model for human skin penetration since it has very 
similar morphology and permeability properties to human skin (Dick and Scott, 1992) and it 
is permitted in regulatory studies for the dermal penetration of cosmetic ingredients 
(SCCS, 2010).  Skin membranes (approximately 6 cm diameter) were cut at a thickness of 
200-400 µm using an electric dermatome.  Each skin membrane was given a unique 
identifying number and stored frozen, at -20oC, on aluminium foil, until required for use. 
 
2.2 In vitro static diffusion cell equipment and measurement of skin integrity 
Details of the diffusion cell assembly used in these investigations are described in the 
OECD Guideline 428 (OECD, 2004a) and Guidance Document No. 28 (OECD, 2004b).  
Discs of dermatomed pig skin approximately 3.3 cm diameter were mounted dermal side 
down in Franz-type glass static diffusion cells (Dugard et al., 1984; Franz, 1975; Scott and 
Clowes, 1992).  Each cell had an exposed area of skin of 2.54 cm2.  The receptor 
chambers were filled with a recorded volume of physiological saline and placed on a 
magnetic stirrer plate in a water bath maintained at a skin temperature of 32 ± 1oC.  Prior 
to use, the skin integrity of each skin membrane was assessed using Electrical Resistance 
(ER) and the cut-off criteria established previously in our laboratory (Davies et al., 2004; 
Heylings et al., 2001).  Resistance across each membrane was measured using a PRISM 
Electronics AIM6401 LCR data bridge and was expressed as k/cell area.  This method 
measures the resistance or impedance of skin samples in diffusion chambers and has 
been shown by several laboratories to be representative of skin barrier function (Davies et 
al., 2004; Lawrence et al., 1997; White et al., 2011).  The chambers were allowed to 
equilibrate in a water bath at 32oC for approximately 30 minutes after-which electrodes 
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were inserted into saline in the receptor chamber side arm and into the saline in the donor 
chamber.  Once stabilised, the resistance value was recorded.  Any skin membranes that 
had an ER value below 3 k, a cut off value described previously for pig skin (Davies et 
al., 2004), were not used in these investigations.  The remaining membranes, from a 
maximum of 5 animals, were split randomly into two groups of 12 cells per reference 
chemical.  To ensure that anomalies were not introduced into these investigations, skin 
membranes from the same 5 animals were used throughout. These intact skin membranes 
were randomly distributed between two groups of diffusion cells.  One group represented 
‘normal’ skin and the other group represented ‘compromised’ skin, following the 10 x tape 
stripping routine described previously (Davies et al., 2015).  The tape stripping method 
followed the standard approach described in test guideline OECD 428 (Trebilcock et al., 
1994), using 22 mm diameter CuDerm D-Squame stripping discs (CuDerm Corporation, 
Dallas, USA) which were applied to the dry skin surface at a constant pressure of 
225 g/cm2 for 5 seconds, using a purpose-built applicator. 
 
2.3 Application of the reference chemicals 
 The reference chemicals used were Benzoic acid, 3-Aminophenol, Caffeine and 
Sucrose (Table 1). After completion of the skin stripping procedure, the receptor chambers 
of the cells (‘normal’ and stripped) were filled with a recorded volume of physiological 
saline receptor fluid.  For each application, a mixture of unlabelled and [14C]-Benzoic acid, 
[14C]-3-Aminophenol, [14C]-Caffeine and [14C]-Sucrose were each separately formulated in 
basic emulsion bases and water to achieve a concentration of 10 mg/mL of each 
compound with a radioactivity content of approximately 1.5 MBq/mL.  Finite applications 
(10 µL/cm2) were applied to the surface of the skin membranes at a dose of 100 µg/cm2 
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and left on the surface of the normal and compromised skin membranes for 24 h.  The 
diffusion cells were placed semi-immersed in a water bath maintained at 32oC ± 1oC. 
 Samples (0.5 mL) of the receptor fluid were taken manually immediately before 
dosing and then at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 16, 20 and 24 h after application, using an 
auto-sampler.  The radioactivity content of the receptor fluid samples was determined by 
LSC analysis following the addition of scintillation fluid.  The volume of fluid in the receptor 
chamber was maintained by the replacement of a volume of receptor fluid, equal to the 
sample volume immediately after each sample was taken.  After 24 h, the donor chamber 
was carefully detached from the cell assembly after which a mild skin washing procedure 
was performed which involved the swabbing of the skin surface firstly with sponges pre-
wetted with a dilute soap solution and then sponges pre-wetted with water.  The flange 
skin (the unexposed/undosed skin which had been held between the donor and receptor 
chamber) was cut away and the epidermis was separated from the dermis by heat 
separation.  The skin tissues were solubilised with tissue digestant prior to analysis by 
LSC. 
 
2.4 Calculations and statistical analyses 
 The time-course absorption into the receptor fluid was calculated by dividing the 
amount of test penetrant at each time point by the area of exposed dermatomed skin 
(2.54 cm2) and plotting the results as amount of penetrant absorbed (µg/cm2) versus time 
(h).  The slope of the absorption profile between given time points provided the average 
rate of absorption of the penetrant per cm2 of the skin (µg/cm2/h) during that period.  The 
proportion (µg/cm2) of test penetrant that was recovered from the individual compartments 
of the system (donor chamber, skin wash, flange, epidermis, dermis and receptor fluid) 
was expressed as a percentage of the total amount applied to the surface of the skin 
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membrane in order to establish the mass balance distribution of the chemical in all the 
experimental compartments.  The normal and compromised skin values were expressed 
as mean ± SEM for each group.  A comparison was made between unstripped ‘normal’ 
skin and ‘compromised’ skin using Student’s t-test for unpaired variates. 
 
3. RESULTS 
3.1 Skin Penetration of Benzoic acid, 3-Aminophenol, affeine and Sucrose 
Benzoic acid gave the highest actual values for skin penetration into the receptor 
fluid over 24 h in both normal and compromised skin with Sucrose giving the lowest values 
for the reference chemicals (Figure 1 and Table 2).  The shapes of the time course profiles 
for each compound were quite similar between normal skin and compromised skin 
(Figure 2).  However, the skin penetration of each compound into the receptor fluid was 
higher in compromised skin in each case.  This trend was reflected across the four 
chemicals when the absorption through the skin was expressed as either % of the dose 
penetrated or as an average rate of absorption or flux (Table 2).  Interestingly, although 
the skin barrier integrity had been compromised to an extent that more test chemical 
penetrated through the skin membrane, the “damaged” membranes still retained 
significant skin barrier capabilities, restricting the access of the penetrant to the receptor 
fluid beneath the skin.  This was in line with previous results of Davies et al (2015) in 
which this tape stripping regime was developed to model barrier function of common skin 
conditions. 
With regard to the magnitude of the change in skin penetration, based on the total 
proportion of the dose reaching the receptor fluid at 24 h, Benzoic acid, 3-Aminophenol, 
Caffeine and Sucrose gave about a 1.5-2.5 fold increase through compromised skin, when 
compared to their normal skin control group.  This was statistically significant for Benzoic 
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acid (p <0.0001), 3-Aminophenol (p <0.01) and Caffeine (p <0.01).  Although a 1.5 fold 
increase absorption of Sucrose was noted through compromised skin, this was not 
statistically significant (p >0.05). 
The relative absorption rates of the compounds demonstrated the same association 
between normal and compromised skin.  Benzoic acid increased from 1.42 µg/cm2/h in 
normal skin to 1.99 µg/cm2/h in compromised skin.  The average skin flux for  
3-Aminophenol increased from 0.67 µg/cm2/h in normal skin to 1.05 µg/cm2/h in 
compromised skin.  For Caffeine, the average absorption rate increased from 
0.21 µg/cm2/h in normal skin to 0.51 µg/cm2/h in compromised skin.  The absorption rate 
of Sucrose was similar between the two skin models with average absorption rates 
between 0-24 h being 0.014 µg/cm2/h for the normal skin and marginally higher at 
0.021 µg/cm2/h through compromised skin. 
 
3.2 Skin Distribution of Benzoic acid, 3-Aminophenol, Caffeine and Sucrose 
The OECD test guideline 428 for the assessment of dermal absorption in vitro also 
requires that dermal absorption to be qualified by the inclusion of the mass balance 
distribution of the compound of interest (OECD, 2004).  Each of the regulatory authorities 
such as SCCS and EFSA in Europe specify which compartments of the mass balance are 
regarded as “dermally absorbed” or “potentially absorbed” for the test chemical being 
investigated in their risk assessment processes (EFSA, 2012; SCCS, 2010).  An important 
consideration in this investigation was to examine where the applied dose of the various 
reference compounds were located at the 24 h time point following application to both 
normal skin and compromised skin. 
The total mass balance recoveries were very good with all the reference 
compounds giving values close to 100% of the dose applied being recovered in the 
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various compartments. This ranged from 97.8% for Benzoic acid to 104% for Caffeine in 
normal skin and 102% for Benzoic acid to 107% for Caffeine in compromised skin.  The 
full mass balance skin distribution of each of the compounds in the two skin types is 
shown in Figure 3 and Tables 3 and 4. 
It was noted that a considerable proportion (34%) of the applied Benzoic acid was 
lost from the skin surface, due to its low molecular weight, into the head space above the 
skin membrane which was maintained at 32 ± 1oC over 24 h.  An almost identical amount 
of Benzoic acid was lost to the atmosphere from compromised skin. Unsurprisingly, since 
normal skin has an intact stratum corneum, more of the Benzoic acid dose was available 
for removal by washing the skin surface (20%) of normal skin at 24 h compared with 10% 
of the applied dose in compromised skin.  Similar and lower proportions of the Benzoic 
acid dose were found in the remaining epidermis and dermis skin in both skin types, but 
significantly more of this compound actually reached the receptor fluid (51% versus 35%) 
in compromised skin. 
3-Aminophenol gave an interesting distribution profile in the skin in the mass 
balance experiments.  Despite much of the stratum corneum having been removed in the 
compromised skin group, about the same proportion of the dose (73-75%) could still be 
removed by surface skin washing at 24 h. Similar amounts of 3-Aminophenol were found 
in the epidermis and dermis in the two skin groups. However, the reduced barrier 
properties of compromised skin allowed a significantly higher proportion of the dose (25%) 
to reach the receptor fluid at 24 h compared with 16% in normal skin. The lower molecular 
weight and more polar 3-Aminophenol (LogPow 0.18) gave similar receptor fluid profiles in 
normal and compromised skin with a short lag phase of around an hour after which 
absorption steadily increased.   
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The more hydrophilic Caffeine penetrated the skin very slowly and, after a small lag 
phase of about half an hour, there was a gradual increase in absorption into the receptor 
phase through both normal and compromised membranes.  The vast majority (over 91%) 
of the dose applied was removed from the surface of both normal and compromised skin 
at 24 h.  Similar low amounts of the dose were found in the epidermis and dermis in the 
two groups.  The only discernible difference in mass balance distribution with Caffeine 
occurred with the receptor dose which was higher in compromised skin at 13% compared 
with only 5% in normal skin.  
Sucrose has physicochemical properties that make it a poor skin penetrant, being 
quite hydrophilic and having a relatively high molecular mass.  Overall, the perturbation in 
the skin barrier by tape stripping had virtually no effect on the skin penetration or 
distribution of topically applied Sucrose.  Indeed, practically all of the applied Sucrose was 
still present on the skin surface after 24 h with 99.8% of the applied dose being removed 
by mild skin washing.  This left only trace amounts of Sucrose in the epidermis and dermis 
(less than 1% of the applied dose).  Although very little Sucrose penetrated the skin, the 
compromised skin group still showed slightly increased absorption at 24 hours (0.6% of 
the applied dose) compared with ‘normal’ skin (0.4%). 
 
4. DISCUSSION 
This investigation is a follow up article to a previous recent publication in this journal 
where we developed a standardised in vitro model to study percutaneous absorption 
through compromised skin (Davies et al., 2015).  We had specifically developed this in 
vitro model since much less is known about the ability of chemicals to permeate through 
the skin when the stratum corneum barrier is physically damaged but not completely 
absent.  Very little is known about the skin distribution of chemicals under such 
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circumstances.  Since the localisation of chemicals within the skin layers is an important 
area of human risk assessment we have refined our in vitro model to include a mass 
balance distribution of various reference chemicals in compromised skin.  This is an 
important part of human risk assessment since consumer and personal care products may 
be used by individuals who have a compromised skin barrier (Goon et al., 2004) or in 
situations such as diaper dermatitis, where infants may have irritated skin (Stamatas et al., 
2011).  Therefore, it is useful to assess the impact this has for different chemicals and how 
it may change the assessment of the bioavailable fraction of the dose applied.  
Furthermore, topical exposure to other industrial chemicals such as pesticides during their 
intended use may also involve contact with damaged skin and an understanding and 
characterisation of dermal absorption and dermal distribution under such conditions is an 
important consideration from a safety perspective.  Our tape stripped dermatomed pig skin 
model has been shown to mimic the conditions of skin damage observed in the clinic, as 
assessed by trans-epithelial water loss (Davies et al., 2015), a non-invasive barrier 
function measure that can be used to assess barrier function in man (Imhof et al., 2009; 
Kim et al., 2006).  One distinct benefit of our proposed model incorporating compromised 
skin is that it does not involve any animal testing, unlike previous models in this area 
where chemicals have been applied to skin membrane of living animals where the tissue 
has been mechanically abraded. 
The in vitro approach as described in test guideline OECD 428 has been used 
successfully for many years to predict dermal absorption of chemicals in man.  We have 
explored whether this in vitro protocol can be adapted to mimic the circumstances 
encountered every day such as the application of consumer products to damaged or 
irritated skin.  One example of this is the use of sunscreen products, many of which 
contain UV absorbers such as zinc oxide and titanium dioxide.  Although it should be 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
14 
 
recognised that some of these products may be presented to the skin as nano materials 
rather than organic molecules dispersed in a formulation (SCCS, 2012).  Sunscreen 
products are often used on sunburnt skin which, of course, is likely to have reduced barrier 
properties, yet little is known about how the systemic availability of these chemicals may 
be altered under these compromised skin conditions. 
The present study has further explored the in vitro compromised skin model 
including an assessment of mass balance distribution, using a range of chemicals with 
different molecular weights and different octanol:water partition coefficients (LogPow).  
Topical application of formulations containing Benzoic acid, 3-Aminophenol, Caffeine and 
Sucrose to normal undamaged skin, and to skin compromised by tape stripping, showed 
that the physicochemical properties that influence dermal absorption in normal skin do, to 
a large extent, still hold for compromised skin in our model.  The physicochemical 
properties of molecular size and polarity and their ability to predict the rate of dermal 
absorption generally prevail. For example, Benzoic acid with its relatively low molecular 
weight and LogPow of 1.87 are physicochemical features consistent with good skin 
penetration.  In contrast, the much higher molecular weight and water soluble nature of 
Sucrose gave consistently low skin penetration values in both skin types. 
An interesting observation here was the reproducibility of the effects across all the 
test penetrants.  We expected a much higher degree of variance in the compromised skin 
group.  However, the robustness of the absorption and distribution data for each chemical 
in compromised skin was remarkably consistent across the twelve replicates in each 
group and for each chemical.  This is probably due to a consistency in the tape stripping 
process itself leading to a uniform model of compromised skin, as we have shown 
previously in this laboratory (Davies et al., 2015). 
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The absorption of the chemicals through the skin into the receptor fluid, often 
presented as a skin flux or absorption rate are common parameters used in the dermal 
absorption field.  However, the in vitro skin models that follow OECD test guideline 428 
and are used in risk assessment to derive a predicted systemic dose of a chemical from its 
formulated product also now require the mass balance distribution of the applied finite (low 
volume) dose of the test chemical to be reported in order to validate the study.  The 
fraction of the dose applied that has reached the bioavailable areas of the epidermis and 
dermis is added to the receptor dose to give the predicted amount of the test chemical 
under investigation that is “systemically available”.  A key study performance criterion in 
OECD test guideline 428 for in vitro dermal absorption assessment (OECD, 2004a) is that 
the mass balance recovery should be 100 +/- 10% of the dose applied.  Any missing dose 
unaccounted for in the mass balance is often presumed to be dermally absorbed due to 
the conservative nature of human risk assessment.  In this investigation, the total 
recoveries were very good and this was achieved for all the chemicals tested in both 
normal and compromised skin.  As shown in Figure 3, there was an inverse relationship 
between the amount washed off the skin at 24 h and the receptor fluid penetrated dose for 
3-Aminophenol, Caffeine and Sucrose.  However, for Benzoic acid, a significant proportion 
of the dose was lost by volatility and a high proportion of the applied dose penetrated both 
normal and compromised skin into the receptor fluid.  Interestingly, from a systemic 
availability perspective, it was not the relatively fast skin penetrant Benzoic acid that 
showed the greatest increase in total systemic exposure, it was the physicochemical 
attributes of Caffeine that gave a 121% increase in predicted systemic availability in the 
compromised skin model compared with only a 35% increase with Benzoic acid.  Although 
we have only studied a small number of chemicals under these controlled conditions, 
these investigations have alerted us to the fact that some compounds, with what may be 
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regarded as intermediate skin penetration characteristics, may actually have the 
physicochemical attributes that make them more prone to greater increases in dermal 
bioavailability in compromised skin.  In contrast, chemicals such as 3-Aminophenol and 
Sucrose that may have previously been considered to be likely candidates for higher 
exposure under these damaged skin conditions by virtue of their physicochemical 
properties did not show a great deal of enhanced dermal absorption through compromised 
skin. 
This investigation on dermal absorption through normal and compromised skin 
involved testing of the actual chemical substance formulated in a basic emulsion base and 
kept all the other conditions of application concentration, dose volume and radioactivity the 
same.  However, it should be noted that the presence of other constituents in a finished 
product, particularly surfactants and emollients or other constituents present to aid 
solubility and dispersion, or even penetration into or through lipid type membranes, if it 
forms part of a personal care product, can also have an influence on the skin penetration 
and systemic exposure of the active ingredient.  The objective of this investigation was to 
identify areas where a study in compromised skin may be a useful exercise to not only 
identify an unknown risk to human health, via increased dermal exposure, but also to 
preserve the approved use of a product where unnecessary restrictions may have been 
placed on it in a risk assessment, when it might be perfectly safe to use even on 
compromised skin. 
More work is needed on a wider range of chemicals and conditions of study beyond 
this “proof of concept” investigation presented here, in order to provide further information 
on how the margin of safety should be considered alongside the intended use of specific 
consumer or personal care products.  In the dermatological products area, this type of 
detailed skin distribution data for different chemicals that can be gained in vitro using 
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normal and compromised skin could be useful to optimise the beneficial actions of new 
topical formulations.  However, we believe that the most useful application of this 
compromised skin model is in the risk assessment area for industrial chemicals, where 
major and arbitrary adjustments to the margin of safety are often made on the basis that 
the chemical may come in contact with human skin with low barrier properties. 
 
5. REFERENCES 
Chiang, A., Tudela, E., Maibach, H.I., 2012. Percutaneous absorption in diseased skin: an 
overview. J. Appl. Toxicol. 32, 537-563. 
Davies, D.J., Ward, R.J., Heylings, J.R., 2004.  Multi-species assessment of electrical 
resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol. 
In Vitro 18, 351-358.  
Davies, D.J., Heylings, J.R., McCarthy, T.J., Correa, C.M., 2015. Development of an in 
vitro model for studying the penetration of chemicals through compromised skin. Toxicol. 
In Vitro 29, 176-181. 
Dey, S., Rothe, H., Page, L., O’Connor, R., Farahmand, S., Toner, F., Marsh, R., 
Wehmeyer, K., Zhou, S., 2014. An in vitro skin penetration model for compromised skin: 
estimating penetration of polyethylene glycol [14C]-PEG-7 phosphate. Skin Pharm. Physiol. 
28, 12-21. 
Dick, I.P., Scott, R.C., 1992. Pig ear as an in vitro model for human skin permeability. J. 
Pharm. Pharmacol. 44, 640-645. 
Dugard, P.H., Walker, M., Mawdsley, S.J., Scott, R.C., 1984.  Absorption of some glycol 
ethers through human skin in vitro.  Environ. Health Persp. 57, 193-197. 
Franz, T.J., 1975.  Percutaneous absorption on the relevance of in vitro data.  J. Invest. 
Dermatol. 64, 190-195. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
18 
 
Goon, A.T-J., Yosipovitch, G., Chan, Y-H., Goh, C-L., 2004.  Barrier repair in chronic 
plaque-type psoriasis. Skin Res.Technol. 10: 10–13. 
Heylings, J.R., Ward, R.J., Hughes, L., 2001.  Comparison of tissue sources for the skin 
integrity function test (SIFT).  Toxicol. In Vitro 15, 597-600. 
Heylings J R and Esdaile D J.  Dermal Absorption of Pesticides In: Dermal Absorption and 
Risk Assessment, Roberts M S and Walters K A.  2nd Ed.  Decker (2007) 
Imhof, R.E., De Jesus, M.E., Xiao, P., Ciortea, L.I., Berg, E.P., 2009.  Closed-chamber 
transepidermal water loss measurement: microclimate, calibration and performance.  Int. 
J. Cosmetic Sci. 31, (2), 97-118. 
Jakasa, I., de Jongh, C.M., Verberk, M.M., Bos, J.D., Kezic, S., 2006. Percutaneous 
penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic 
dermatitis compared with control subjects. Brit. J. Dermatol. 155, 104-109. 
Kezic, S., Nielsen, J.B., 2009. Absorption of chemicals through compromised skin. Int. 
Arch. Occup. Environ. Health 82, 677-688.  
Kim, D-W., Park, J-Y., Na, G-Y., Lee, S-J., Lee, W-J., 2006.  Correlation of clinical 
features and skin barrier function in adolescent and adult patients with atopic dermatitis. 
Int. J. Dermatol., 45, 698 –701. 
Lawrence, J.N., 1997.  Electrical resistance and tritiated water permeability as indicators 
of barrier integrity of in vitro human skin.  Toxicology In Vitro, 11, 241-249. 
OECD, 2004a.  Test Guideline 428. Skin Absorption: In Vitro Method.  Organisation for 
Economic Co-operation and Development, Paris. 
OECD, 2004b.  Guidance Document No. 28.  The Conduct of Skin Absorption Studies. 
Organisation for Economic Co-operation and Development, Paris. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
19 
 
Scientific Committee on Consumer Safety.  Opinion on Basic Criteria for the In Vitro 
Assessment of Dermal Absorption of Cosmetic Ingredients.  Updated 22nd June 2010.  
SCCS/1358/10. 
Scientific Committee on Consumer Safety Guidance on the Safety Assessment of 
Nanomaterials in Cosmetics (SCCS/1484/12)  
Scott, R.C., Clowes, H.M., 1992. In vitro percutaneous experiments: A guide to the 
technique for use in toxicology assessments.  Toxicol. Methods 2, 113-123. 
Stamatas, G.N., Zerweck, C., Grove, G., Martin K.M., 2011.  Documentation of impaired 
epidermal barrier in mild and moderate diaper dermatitis in vivo using non-invasive 
methods.  Pediatric Dermatology 28, (2), 99–107. 
Trebilcock, K.L., Heylings, J.R., Wilks, M.F., 1994.  In vitro tape stripping as a model for in 
vivo skin stripping.  Toxicol. In Vitro 8, (4), 665-667.  
White, E.A., Horne, A., Runciman, J., Orazem, M.E., Navidi, W.C., Roper, C.S., Bunge, 
A.L., 2011.  On the correlation between single-frequency impedance measurements and 
human skin permeability to water.  Toxicol. In Vitro 27, (2), 2085-2014. 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
20 
 
Fig.1.  Profile of skin penetration of reference chemicals through normal and compromised pig skin (Mean, n 
= 12 each) 
 
Normal=Control untreated skin. 
Compromised=10xTape stripped skin.  
Fig.2  Individual comparison of the skin penetration of reference chemicals through normal and 
compromised pig skin (Mean, n = 12 each) 
 
Normal=Control untreated skin. 
Compromised=10xTape stripped skin. 
Normal skin Compromised skin
(A)  Benzoic acid    (B) 3-Aminophenol
  (C) Caffeine    (D)  Sucrose
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Fig.3  Mass balance distribution of four reference chemicals through normal and compromised pig skin (Mean ± SEM, n = 12 each) 
 
 
(A) Normal skin - Mass balance distribution by compartment (B) Normal skin - Mass balance distribution by reference chemical 
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Table 1 
Physical and chemical properties of the reference chemicals tested 
 
Table 2 
Absorption of Benzoic acid, 3-Aminophenol, Caffeine and Sucrose through normal and compromised pig 
skin (Mean ± SEM, n = 12 each) 
 
Normal=Control untreated skin. 
Compromised=10xTape stripped skin.  
Table 3 
Mass balance distribution through normal pig skin following 24 hour exposure to four reference chemicals 
(Mean ± SEM, n = 12 each) 
 
Normal=Control untreated skin. 
Systemically available=Penetrated+remaining 
  
Molecular weight
Octanol-water 
partition coefficient 
(LogPow)
194 342
1.87 0.18 -0.07 -3.76
Benzoic acid 3-Aminophenol Caffeine Sucrose
122 109
Time (h) Normal Compromised Normal Compromised Normal Compromised Normal Compromised
0.54 ± 0.10
0.36 ± 0.05 0.55 ± 0.11
0.01 ± 0.002 0.02 ± 0.004
Amount 
(µg/cm²)
%
Rate 
(µg/cm²/h)
15.9 ± 1.24 24.6 ± 2.44
0.67 ± 0.06 1.05 ± 0.11
5.01 ± 0.61 12.6 ± 2.38
5.00 ± 0.60 12.5 ± 2.37
0.21 ± 0.03 0.51 ± 0.10
24 34.8 ± 1.41 51.1 ± 2.95
0-24 1.42 ± 0.06 1.99 ± 0.11
Benzoic Acid 3-Aminophenol Caffeine Sucrose
24 34.3 ± 1.39 50.5 ± 2.91 15.6 ± 1.22 24.3 ± 2.42 0.35 ± 0.05
Compartment
Volatilty
Donor Chamber
Skin Wash at 24 h
Flange
Remaining Epidermis
Dermis
Penetrated 
Systemically available
TOTAL
Percentage dose applied
Benzoic acid 3-Aminophenol Caffeine Sucrose
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
34.1 ± 0.09 - - -
0.19 ± 0.02 0.23 ± 0.03 0.05 ± 0.02 0.23 ± 0.20
20.3 ± 1.05 74.6 ± 1.68 96.5 ± 1.08 99.8 ± 0.76
0.72 ± 0.07 1.16 ± 0.15 0.30 ± 0.05 1.30 ± 0.20
34.8 ± 1.41 15.9 ± 1.24 5.00 ± 0.60 0.36 ± 0.05
2.73 ± 0.24 3.42 ± 0.27 0.97 ± 0.14 1.01 ± 0.10
4.99 ± 0.33 4.05 ± 0.46 0.76 ± 0.05 0.36 ± 0.02
42.5 ± 1.20 23.4 ± 1.57 6.73 ± 0.70 1.72 ± 0.15
97.8 ± 0.93 99.4 ± 0.50 104 ± 0.86 103 ± 0.49
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Table 4 
Mass balance distribution through compromised pig skin following 24 hour exposure to four reference 
chemicals (Mean ± SEM, n = 12 each) 
 
Compromised=10xTape stripped skin.  
Systemically available=Penetrated+remaining 
 
  
Compartment
Volatility
Donor Chamber
Skin Wash at 24 h
Flange
Remaining Epidermis
Dermis
Penetrated 
Systemically available
TOTAL
Percentage dose applied
Benzoic acid 3-Aminophenol Caffeine Sucrose
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
34.4 ± 0.12 - - -
0.25 ± 0.06 0.49 ± 0.11 0.16 ± 0.05 0.063 ± 0.02
9.88 ± 2.06 73.3 ± 3.05 91.3 ± 3.10 101 ± 1.03
0.61 ± 0.05 1.33 ± 0.17 0.36 ± 0.06 1.27 ± 0.76
12.5 ± 2.37 0.55 ± 0.11
1.81 ± 0.25 2.76 ± 0.28 0.99 ± 0.13 0.40 ± 0.06 
4.36 ± 0.47 4.06 ± 0.34 1.38 ± 0.09 0.33 ± 0.03
57.3 ± 2.55 31.4 ± 2.46 14.9 ± 2.43 1.27 ± 0.13
51.1 ± 2.95 24.6 ± 2.44
102 ± 1.74 106 ± 3.26 107 ± 1.29 103 ± 0.47
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Highlights 
 An in vitro model of pig skin compromised by tape stripping has been investigated 
 Skin penetration and distribution of reference chemicals was established over 24h 
 Although impaired, skin compromised using this model retained barrier capabilities 
 This skin model could be useful for human risk assessment of consumer products 
